The induction of specific transplantation tolerance, a state resulting in the acceptance of tissues from a particular donor type while maintaining otherwise normal immune reactivity, is a major goal of transplantation research. Transplantation of kidney allografts between various donor/recipient combinations have demonstrated the overwhelming importance of matching for the major histocompatibility complex (MHC) class II region in inducing specific tolerance to vascularized grafts in miniature swine, and similar conclusions may be drawn from clinical studies. During the previous project period we demonstrated that transfer of class Il genes, through retrovirus-mediated transduction of autologous bone marrow cells, could substitute for allogeneic bone marrow transplantation in inducing specific transplantation tolerance to subsequent fully mismatched renal allografts. Surprisingly, specific tolerance was successfully achieved by transferring the class Il DR locus alone. Although expression of the allogeneic DR transgene was low and limited to a fraction of bone marrow-derived cells, matching for DR alone appeared to control immunity to alloantigens displayed on the vascularized organ. In view of the powerful tolerogenic effects of DR in this model we hypothesize that induction of class II-dependent tolerance is a dominant phenomenon which may be mediated by identity for at least one class II product, and which only requires a low signal level (possibly peptides) present on an appropriate bone marrow-derived cell type in the early phase of the hematopoietic system reconstitution. In order to test this hypothesis we propose in this renewal to: l) Test whether identity to class II DQ alone can also control tolerance induction to primarily vascularized organ transplants in miniature swine; 2) Examine possible mechanisms leading to long-lasting unresponsiveness; 3) Characterize the bone marrow-derived cell type which induces tolerance via class II gene therapy; and 4) Examine the correlation between long-term expression of the transferred genes and long-lasting tolerance. Information obtained from these studies will be critical in defining the mode of action of the class II molecules in tolerance induction and will permit the design of appropriate protocols for future gene therapy approaches to tolerance of vascularized organs in man.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI033053-10
Application #
6373283
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Prasad, Shiv A
Project Start
1992-07-01
Project End
2003-04-30
Budget Start
2001-05-01
Budget End
2003-04-30
Support Year
10
Fiscal Year
2001
Total Cost
$430,821
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Matter-Reissmann, Ulrike B; Sonntag, Kai-Christian; Gilli, Urs O et al. (2004) Human Fas-ligand expression on porcine endothelial cells does not protect against xenogeneic natural killer cytotoxicity. Xenotransplantation 11:43-52
LeGuern, Christian (2003) Regulation of T-cell functions by MHC class II self-presentation. Trends Immunol 24:633-8
Shimada, Hideaki; Germana, Sharon; Hayashi, Hideki et al. (2003) Expression of MHC class II DQ alpha/beta heterodimers from recombinant polycistronic retroviral genomes. Surg Today 33:183-9
Denaro, Maria; Kolber-Simonds, Donna; Schad, Victoria et al. (2002) Expression of xenogeneic MHC class II molecules in HLA-DR(+) and -DR(-) cells: influence of retrovirus vector design and cellular context. Xenotransplantation 9:115-24
Baron, C; Sachs, D H; LeGuern, C (2001) A particular TCR beta variable region used by T cells infiltrating kidney transplants. J Immunol 166:2589-96
Seebach, J D; Schneider, M K; Comrack, C A et al. (2001) Immortalized bone-marrow derived pig endothelial cells. Xenotransplantation 8:48-61
Salmon, H; Johnson, I; Germana, S et al. (2000) Dendritic cells enriched from swine thymus co-express CD1, CD2 and major histocompatibility complex class II and actively stimulate alloreactive T lymphocytes. Scand J Immunol 52:164-72
Sonntag, K C; Nebhard, N; Haller, G W et al. (2000) Assessment of transduction rates of porcine bone marrow. J Hematother Stem Cell Res 9:721-6
Shimada, H; Germana, S; Sonntag, K C et al. (1999) MHC class II alpha/beta heterodimeric cell surface molecules expressed from a single proviral genome. Hum Gene Ther 10:2397-405
Shimada, H; Alexander, R C; Germana, S et al. (1999) Recombinant retrovirus vectors for the expression of MHC class II heterodimers. Surg Today 29:533-41

Showing the most recent 10 out of 18 publications